Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationCyclophosphamidePeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeMelphalanMultiple MyelomaTransplantation ConditioningTransplantation, HomologousSalvage TherapyLymphoma, Non-HodgkinRemission InductionAntineoplastic AgentsDisease-Free SurvivalEtoposideStem CellsHodgkin DiseaseCytarabineRecurrenceSurvival RateCarmustineDoxorubicinMyeloablative AgonistsVincristineBone Marrow TransplantationThiotepaHematopoietic Stem Cell MobilizationChemotherapy, AdjuvantSurvival AnalysisGraft vs Host DiseaseBone Marrow PurgingAntineoplastic Agents, AlkylatingHematologic NeoplasmsWhole-Body IrradiationBusulfanPrognosisLymphoma, Mantle-CellRetrospective StudiesDexamethasoneAmyloidosisAntibodies, Monoclonal, Murine-DerivedHematopoietic Stem CellsFollow-Up StudiesBoronic AcidsPyrazinesIfosfamideGraft SurvivalPrednisoneLymphoma, FollicularTime FactorsGranulocyte Colony-Stimulating FactorAntigens, CD34Induction ChemotherapyLymphoma, T-Cell, PeripheralThalidomideAutograftsLiver TransplantationCisplatinLymphomaLeukapheresisDose-Response Relationship, DrugDrug Administration ScheduleLymphoma, Large B-Cell, DiffusePodophyllotoxinMesenchymal Stem Cell TransplantationNeoplasm, ResidualMaintenance ChemotherapyLeukemia, Myeloid, AcuteTransplantation ChimeraCarboplatinImmunosuppressive AgentsMitoxantroneTissue DonorsCord Blood Stem Cell TransplantationProspective StudiesBreast NeoplasmsLymphoma, B-CellNeoplasm Recurrence, LocalCell TransplantationMyelodysplastic SyndromesNeoplasms, Second PrimaryIdarubicinKidney TransplantationNeoplasm StagingNeutropeniaAntibodies, MonoclonalEnteropathy-Associated T-Cell LymphomaMethotrexateEmbryonic Stem CellsLeukemia, Plasma CellFeasibility StudiesBlood Component RemovalInfusions, SpinalNeoplasmsLeukemia, MyeloidHistocompatibility TestingAdult Stem Cells